Submit Deal

David Q. Anderson

General Partner at AMPERSAND CAPITAL PARTNERS

Investor

Deal Bio

Total Deals4

Valued Deals2

Total Value£916M

Avg. Deal Size£458M

Market Context

Expertise (4)

Key Relationships

Sort

Germany

Pharmaceuticals

AcquisitionPrivatePrivate Equity

target

VIBALOGICS

bidder

Ampersand Capital Partners

value n/a

2 dealmakers

Australia

Electrical Components

MajorityAcquisitionPrivate EquityPrivate

target

L3harris (applied Kilovolts And Analytical Instrumentation Business)

bidder

Adaptas Solutions

value n/a

3 dealmakers

United States

Biotechnology

DomesticPrivate EquityMajorityPrivateAcquisitionDisposal

target

Nektar Therapeutics (commercial Pegylation Reagent Manufacturing Business In Alabama)

bidder

Ampersand Capital Partners

£69m

11 dealmakers

United States

Biotechnology

MajorityAcquisitionCross BorderPrivate EquityPublic

target

Avid Bioservices

bidder

Ampersand Capital Partners

£846m

25 dealmakers

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.